Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.

scientific article

Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.OPHTHA.2013.12.035
P932PMC publication ID4047168
P698PubMed publication ID24613825

P50authorEmily ChewQ24266614
Philip J RosenfeldQ114427406
Susan B BresslerQ114739669
Age-Related Eye Disease Study 2 Research GroupQ117242065
Elvira AgrónQ83234331
Traci E ClemonsQ92993074
P2093author name stringNancy Huynh
Benjamin P Nicholson
P2860cites workA randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8Q24544001
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9Q24546140
Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular DegenerationQ28290149
Prevalence of age-related macular degeneration in the United StatesQ29614964
Ranibizumab for neovascular age-related macular degenerationQ29617549
Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studiesQ30800516
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.Q34343037
Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.Q34491990
Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27Q34493282
The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye studyQ34528853
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17Q34653094
The relationship of cataract and cataract extraction to age-related macular degeneration: the Beaver Dam Eye StudyQ36140110
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)Q36360812
Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)Q36996217
Progression of age-related macular degeneration after cataract surgeryQ43245378
Cataract surgery in high-risk age-related macular degeneration: a randomized controlled trial.Q43287122
Risk of fractures following cataract surgery in Medicare beneficiariesQ45787525
Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration.Q45983717
Prevalence of cataract and pseudophakia/aphakia among adults in the United StatesQ46196467
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR resultsQ46940817
Cataract surgery and the 10-year incidence of age-related maculopathy: the Blue Mountains Eye Study.Q50476310
Long-term visual outcome after cataract surgery: comparison of healthy eyes and eyes with age-related macular degeneration.Q50975726
Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantationQ71692991
Cataract surgery is associated with a higher rate of photodynamic therapy for age-related macular degenerationQ79707760
Is pseudophakia a risk factor for neovascular age-related macular degeneration?Q80050199
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1Q80553646
Phacoemulsification does not induce neovascular age-related macular degenerationQ80836853
Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trialsQ84601830
P433issue6
P921main subjecteye diseaseQ3041498
macular degenerationQ27429789
P304page(s)1229-1236
P577publication date2014-03-07
P1433published inOphthalmologyQ7098109
P1476titleVisual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.
P478volume121

Reverse relations

cites work (P2860)
Q92200968A case report detailing use of a new intraocular lens with advanced technology, designed specifically for patients with center-involving macular disorders
Q35544915Cataract surgery and age-related macular degeneration. An evidence-based update.
Q51723541Cataract surgery in patients with neovascular age-related macular degeneration.
Q36504075Cost-Utility Analyses of Cataract Surgery in Advanced Age-Related Macular Degeneration
Q58731323Effect of Phacoemulsification on Visual Acuity and Macular Morphology in Patients with Wet Age-Related Macular Degeneration
Q64093434First-Year Outcomes of Cataract Surgery Combined with Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
Q34597977Metamorphopsia and letter recognition
Q42367908MicroRNAs: new players in cataract
Q55919856Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q89958068Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q90307768Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q57689012Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Q93360900Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Q88615813Supplementation with macular carotenoids improves visual performance of transgenic mice
Q38261108The impact of cataract surgery on AMD development and progression.
Q50522077[Multifocal electroretinography for therapeutic effect evaluation of intravitreal injection Lucentis for wet age-related macular degeneration].

Search more.